MedPath

COMPARISON BETWEEN TWO DIFFERENT DOSES (300MG AND 600MG) OF THE DRUG GABAPENTIN TO ASSESS POST OPERATIVE PAIN TOLERANCE OF PATIENTS UNDERGEOING LOWER LIMB SURGERIES UNDER SPINAL ANAESTHESIA

Phase 4
Registration Number
CTRI/2019/01/017145
Lead Sponsor
MGM MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

BOTH MALE AND FEMALE PATIENTS OF AGE GROUP 18-65 YRS RECEIVING SPINAL ANAESTHESIA FOR ELECTIVE LOWER LIMB SURGERIES UNDER ASA GRADE 1 AND 2

Exclusion Criteria

1. PATIENTS WITH ALLERGY TO GABAPENTIN

2. PATIENTS SUFFERING FROM EPILEPSY, LIVER AND RENAL DISEASE, ANY CHRONIC PAIN SYNDROMES, PSYCHIATRIC ILLNESS

3. PATIENTS REQUIRING SURGICAL DURATION MORE THAN 3 HOURS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
COMPARE TOTAL DURATION OF ANALGESIA AND TOTAL NUMBER OF ANALGESICS REQUIRED IN THE FIRST 24 HOURS AFTER SURGERYTimepoint: 24 HOURS
Secondary Outcome Measures
NameTimeMethod
COMPARE SIDE EFFECTS OF THE TWO DOSES OF GABAPENTIN IF ANYTimepoint: 24 HOURS
© Copyright 2025. All Rights Reserved by MedPath